Close Menu
    Facebook X (Twitter) Instagram
    Trending
    • China Slams Trump’s Tariff Threat to BRICS Nations: “We Oppose Coercion Through Tariffs”
    • Senate’s “Most Dangerous” Tax Bill Sparks Outrage as Democrats Unite Against Billionaire Bailout
    • Paramount’s $16 Million Settlement with Trump Over ‘60 Minutes’ Lawsuit
    • Cricmax Connect: Powering the Organic Growth of Cricket in America
    • Political Constraints and Losses in Operation Sindoor – Why the Silence?
    • India’s Operation Sindhu: Rescuing Thousands from Iran-Israel Conflict
    • India Rejects Pakistan’s Court of Arbitration, Upholds Indus Waters Treaty
    • The Golf GTI EDITION 50: Fastest Volkswagen Ever on the Nürburgring
    • About
    • Careers
    • Contact
    • Privacy Policy
    Facebook X (Twitter) Instagram
    Digpu NewsDigpu News
    Tuesday, July 8
    • Home
    • World
    • India
    • Business
    • Tech
    • Sports
    • More
      • Achievers
      • Auto Tech
      • Diplomatic Diary
      • Dil Paziir
      • Education
      • Entertainment
      • Finance
      • Health
      • Opinion
      • Politics
      • Press release
      • Startup
      • Science & Nature
      • Travel
    Digpu NewsDigpu News
    Home » India News » Sputnik Vaccine would be available for Indians by next week

    Sputnik Vaccine would be available for Indians by next week

    By News DeskMay 13, 2021 Health No Comments3 Mins Read
    Sputnik Vaccine would be available for Indians by next week
    Share
    Facebook Twitter LinkedIn Pinterest Email

    Hopefully, the sale of the limited supply that has come from Russia will begin next week : Dr VK Paul

     New Delhi [India]

    Amid reports of the shortage of COVID-19 vaccine in various states, Sputnik vaccine has arrived in India, and “hopefully” it will be available in the market from next week, said Dr VK Paul, member (health) of the NITI Aayog, on Thursday.

     “Sputnik vaccine has arrived in India. I’m happy to say that we’re hopeful that it’ll be available in the market next week. We’re hopeful that the sale of the limited supply that has come from there (Russia) will begin next week, said Dr Paul while addressing media.

     He said the production of Sputnik is scheduled to begin in India by July. “Further supply will also follow. Its production will begin in July and it is estimated that 15.6 crore doses will be manufactured in that period,” Dr Paul said.

    Sputnik Vaccine would be available for Indians by next week

     Notably, Sputnik V is the third vaccine India has given go-ahead to after Covishield, developed by Oxford University and AstraZeneca and Covaxin, the indigenous vaccine manufactured by Bharat Biotech. Covishield is manufactured by the Serum Institute of India.

     Talking about the Central government’s move to increase the availability of COVID-19 vaccines, the NITI Aayog member said that overall, 216 crore doses of vaccines will be manufactured in India between August and December – “for India and for Indians”.

     “There should be no doubt that vaccine will be available for all as we move forward…Any vaccine that is approved by FDA, WHO can come to India. Import license will be granted within 1-2 days. No import license is pending,” he added.

     He further informed that the Department of Biotechnology, along with other concerned departments and the Ministry of External Affairs (MEA) has been in touch with Pfizer, Moderna, Johnson and Johnson from the initial days of vaccine production.

     “They were officially asked if they would like to send doses to or manufacture in India. We will find partners and assist. They had said that they are working in their own way and they would talk of vaccine availability in the third quarter in 2021. We are connected to them. I’m hopeful that they will step forward to increase availability in India. We invite them to manufacture here along with our companies. Johnson and Johnson did a good job. They accepted this offer under Quad,” Dr Paul said.

     He added that nearly 18 crore doses of the COVID-19 vaccine have been administered in India.

     “In the US, the number stands around 26 crores. So, India stands in the third position. We are happy to report that one-third of 45 and above are protected. 45 and above age group contributes to 88 per cent of deaths. So you can imagine, how many dents it would have made to reduce the risk of death of this population,” the NITI Aayog member added.

     Dr Paul also informed that Bharat Biotech has welcomed the offer of other companies manufacturing Covaxin to increase its production in the country.

     “People say that Covaxin should be given to other companies for manufacturing. I am happy to say that Covaxin manufacturing company (Bharat Biotech) has welcomed this when we discussed it with them. Under this vaccine, a live virus is inactivated and this is done only in BSL3 labs. Not every company has this. We give an open invitation to companies who want to do this. Companies that want to manufacture Covaxin, should do it together. The government will assist so that capacity is increased,” he said.

    NITI Aayog Sputnik V vaccine
    News Desk
    • Website
    • Facebook
    • X (Twitter)
    • Pinterest
    • Instagram
    • Tumblr
    • LinkedIn

    Stay tuned to read latest updates and news from all around the world.

    Keep Reading

    Political Constraints and Losses in Operation Sindoor – Why the Silence?

    Leaked Tape Sparks Controversy Over Manipur Chief Minister’s Role

    WHO Declares MPOX a Public Health Emergency: A New Global Health Challenge Emerges

    Hindenburg Research Exposes SEBI Chairperson’s Alleged Ties to Adani Group’s Offshore Financial Network

    Discrepancies in 2024 Elections: A Deep Dive into EVM Vote Counting Irregularities

    The Reality Behind India’s Infrastructure Boom: Achievements, Issues, and Future Plans

    Add A Comment
    Leave A Reply

    You must be logged in to post a comment.

    Latest

    China Slams Trump’s Tariff Threat to BRICS Nations: “We Oppose Coercion Through Tariffs”

    July 7, 2025

    Senate’s “Most Dangerous” Tax Bill Sparks Outrage as Democrats Unite Against Billionaire Bailout

    July 2, 2025

    Paramount’s $16 Million Settlement with Trump Over ‘60 Minutes’ Lawsuit

    July 2, 2025

    Cricmax Connect: Powering the Organic Growth of Cricket in America

    July 1, 2025

    China Slams Trump’s Tariff Threat to BRICS Nations: “We Oppose Coercion Through Tariffs”

    July 7, 2025

    Senate’s “Most Dangerous” Tax Bill Sparks Outrage as Democrats Unite Against Billionaire Bailout

    July 2, 2025

    Paramount’s $16 Million Settlement with Trump Over ‘60 Minutes’ Lawsuit

    July 2, 2025

    Cricmax Connect: Powering the Organic Growth of Cricket in America

    July 1, 2025
    About
    About

    Digpu News – Free Voice With A Critical Edge: At Digpu.com, we embody the spirit of ‘Free Voice With A Critical Edge.‘ Our mission is to reinvent the very idea of news. Launched in 2018, our independent daily English online news channel has set the standard for true journalism—emphasizing accuracy, reliability, relevance, and impartiality.

    Follow Us!
    • Facebook
    • Twitter
    • Pinterest
    • Instagram
    • YouTube
    Highlights

    China Slams Trump’s Tariff Threat to BRICS Nations: “We Oppose Coercion Through Tariffs”

    Diplomatic Diary July 7, 2025

    Senate’s “Most Dangerous” Tax Bill Sparks Outrage as Democrats Unite Against Billionaire Bailout

    Paramount’s $16 Million Settlement with Trump Over ‘60 Minutes’ Lawsuit

    Cricmax Connect: Powering the Organic Growth of Cricket in America

    Subscribe to Digpu
    © 2025 Digpu News Network. All rights reserved.
    • Terms of Use
    • Site Map
    • Privacy Policy
    • Disclaimer

    Type above and press Enter to search. Press Esc to cancel.